Want to see TRDA full AI Analyst Report?
Entrada Therapeutics Inc (TRDA) Q4 2024 Earnings Report
TRDA Q4 2024 EPS Results
- Actual EPS
- $0.03
- Consensus EPS
- -$0.67
- Beat/Miss
- Beat by +$0.70
- One Year Ago EPS
- -$0.29
TRDA Q4 2024 Revenue Results
- Actual Revenue
- $37.40M
- Expected Revenue
- $13.12M
- Beat/Miss
- Beat by +$24.28M
- YoY Revenue Growth
- -10.63%
Earnings Announcement Details
- Quarter
- Q4 2024
- Date
- 02/27/2025
- Time
- Before Open
- Conference Call
- Thursday, February 27, 2025
TRDA Upcoming Earnings
Entrada Therapeutics Inc's next earnings date is estimated for November 10, 2026, based on past reporting schedules.
Q4 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2024 Earnings Slide Deck
Q4 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
TRDA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 10, 2026 | 2026 (Q3) | -1.01- | -1.06 | ― | ― |
| Aug 05, 2026 | 2026 (Q2) | -1.05-1.01 | -1.04 | 2.88% (+0.03) | |
| May 07, 2026 | 2026 (Q1) | -1.04-0.95 | -0.42 | -126.19% (-0.53) | |
| Feb 26, 2026 | 2025 (Q4) | -1.15-0.94 | 0.03 | -3233.33% (-0.97) | |
| Nov 06, 2025 | 2025 (Q3) | -0.94-1.06 | -0.35 | -202.86% (-0.71) | |
| Aug 06, 2025 | 2025 (Q2) | -0.85-1.04 | 1.55 | -167.10% (-2.59) | |
| May 08, 2025 | 2025 (Q1) | -0.79-0.42 | 0.68 | -161.76% (-1.10) | |
| Feb 27, 2025 | 2024 (Q4) | -0.670.03 | -0.29 | 110.34% (+0.32) | |
| Nov 05, 2024 | 2024 (Q3) | -0.73-0.35 | 1.02 | -134.31% (-1.37) | |
| Aug 13, 2024 | 2024 (Q2) | 0.361.55 | -0.78 | 298.72% (+2.33) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
